Document is current
Any future updates will be listed below
-
Authors
Beijert, I. J.
van den Burgt, Y.
Hentschel, A. E.
Bosschieter, J.
Kauer, P. C.
Lissenberg-Witte, B. I.
van Moorselaar, R. J.A.
Nieuwenhuijzen, J. A.
Steenbergen, R. D.M.
- License Information
-
More Information
Article History
Received: 20 June 2024
Accepted: 21 September 2024
First Online: 16 October 2024
Declarations
:
: The study protocol was approved by the Medical Ethics Committee (2018.355 [16-10-2018], WO 18.155 [21-12-2018]). All participants gave informed written consent for study participation prior to inclusion.
: R.D.M. Steenbergen holds a minority stake in Self-screen B.V., a spin-off company of Amsterdam UMC, location VUmc, which owns patents and products related to the development of methylation markers for cervical screening. R.D.M. Steenbergen and J.A. Nieuwenhuijzen are inventors on patents related to this work. The other authors have no conflict of interest to declare.
